PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22434639-9	2012	The 1B4M-DTPA-coupled conjugate was further evaluated in a high HER2-expressing tumor model.	2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid	4-13	erb-b2 receptor tyrosine kinase 2	Homo sapiens	64-68	
20707718-1	2010	PURPOSE: The purposes of this study were to evaluate the organ biodistribution, pharmacokinetics, immunogenicity, and tumor uptake of (111)Indium ((111)In)-MxDTPA-trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancers and to determine whether (90)Y-MxDTPA-trastuzumab should be evaluated in subsequent clinical therapy trials.	2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid	156-162	erb-b2 receptor tyrosine kinase 2	Homo sapiens	198-232	
20707718-1	2010	PURPOSE: The purposes of this study were to evaluate the organ biodistribution, pharmacokinetics, immunogenicity, and tumor uptake of (111)Indium ((111)In)-MxDTPA-trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancers and to determine whether (90)Y-MxDTPA-trastuzumab should be evaluated in subsequent clinical therapy trials.	2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid	156-162	erb-b2 receptor tyrosine kinase 2	Homo sapiens	234-238